When accessing the CDB site through an internal Novo Nordisk IP address, you will see "Your Location" as NN Internal instead of a country. This only applies to internal NN IP addresses. Thank you for your patience while the development team is upgrading this feature.

Your Location: USA

Help Join the Cause Submit Data

Bookmark and Share

Diabetes Types

Pre-diabetes

About Pre-diabetes

Pre-diabetes, also known as impaired glucose tolerance (IGT) is a term used to describe people who are at increased risk of developing type 2 diabetes...

More...

Type 1 Diabetes

About Type 1 Diabetes

Type 1 diabetes, previously called insulin-dependent diabetes mellitus (IDDM) or juvenile-onset diabetes, accounts for approximately 5% of all diagnosed cases of diabetes...

More...

Type 2 Diabetes

About Type 2 Diabetes

Type 2 diabetes, previously called non-insulin-dependent diabetes mellitus (NIDDM) or adult-onset diabetes, accounts for approximately 85-95% of all diagnosed cases of diabetes...

More...

Gestational Diabetes

About Gestational Diabetes

Gestational diabetes mellitus (GDM) is a glucose intolerance which is first diagnosed during pregnancy...

More...

Other Diabetes Types

Diabetes resulting from other aetiologies, including specific genetic conditions, surgery, drugs, malnutrition, infections, and other illnesses...

More...

Return To Top

See How Your Country Measures Up

Get diabetes data in four key areas: Quality of Care, Prevalence of Diabetes, Cost of Diabetes, and Access to Care

Diabetes Data

Join the Cause

Answer the call to measure, share, and improve

Join the Cause

Read About the Global Impact of Diabetes

Learn about the human and economic impact of diabetes in other countries

Briefing Books

References:
1. Centers for Disease Control and Prevention. National diabetes fact sheet, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011.
2. American Diabetes Association. Standards of medical care in diabetes – 2011. Diabetes Care 2011; 34(Suppl 1): S11-S61.
3. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
4. Centers for Disease Control and Prevention. Agency for Healthcare Research and Quality. Frequently Asked Questions: Pre-diabetes. http://www.cdc.gov/diabetes/faq/prediabetes.htm. 2009.
5. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
6. Diabetes Prevention Program Research Group. Design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care. 1999 Apr;22(4):623-34.
7. International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation, 2006.
8. International Diabetes Federation. Diabetes in the young. IDF Diabetes Atlas, 5th edn. Brussels, Belgium: International Diabetes Federation, 2011.
9. International Diabetes Federation. What is diabetes. IDF Diabetes Atlas, 5th edn. Brussels, Belgium: International Diabetes Federation, 2011.
10. Carroll AE, Ackermann RT, Brizendine EJ, Shen C, Marrero D. Does age at diabetes diagnosis influence long-term physical and behavioural outcomes. Diabetes Care. 2007;30(11):2859-1860.
11. Mehers KL, Gillespie KM. The genetic basis for type 1 diabetes. British Medical Bulletin. 2008;88(1):115-129.
12. International Diabetes Federation. Type 1 diabetes. IDF Diabetes Atlas, 3rd edn. Brussels, Belgium: International Diabetes Federation, 2006
13. International Diabetes Federation. Diabetes in the young: a global perspective [background paper]. IDF Diabetes Atlas, 4th edn. Brussels, Belgium: International Diabetes Federation, 2009
14. Amed S, Daneman D, Mahmud FH, Hamilton J. Type 2 diabetes in children and adolescents. Expert Rev Cardiovasc Ther. 2010 Mar;8(3):393-406.
15. Kaufman FR. Type 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metab. 2002 May;15 Suppl 2:737-44. Review.
16. International Diabetes Federation. Increasing incidence. IDF Diabetes Atlas, 3rd edn. Brussels, Belgium: International Diabetes Federation, 2006
17. Henderson JN, Allen KV, Deary IJ, Frier BM. Hypoglycaemia in insulin-treated type 2 diabetes: frequency, symptoms, and impaired awareness. Diabet Med. 2003;20:1016-1021.
18. International Diabetes Federation. Diabetes. IDF Diabetes Atlas, 5th edn. Brussels, Belgium: International Diabetes Federation, 2011.
19. Fagot-Campagna A, Narayan KM, Imperatore. Type 2 diabetes in children [editorial]. BMJ. 2002;322(7283): 377-378.
20. White JR. The cost of managing diabetes mellitus: focus on the oral pharmacologic management of type II diabetes. J Managed Care Pharm 1999; 113-20.
21. Haire-Joshu D, Glasgow RE, Tibbs TL.Smoking and diabetes. Diabetes Care 1999;22:1887–1898.
22. American Diabetes Association. Smoking and diabetes (Position Statement). Diabetes Care 2004;27(Suppl. 1):S74–S75.
23. Ridderstråle M, Groop L. Genetic dissection of type 2 diabetes. Mol Cell Endocrinol. 2009 Jan 15;297(1-2):10-7. Epub 2008 Oct 19. Review.
24. International Diabetes Federation. What is diabetes. IDF Diabetes Atlas, 4th edn. Brussels, Belgium: International Diabetes Federation, 2009
25. Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, Hu FB. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care. 2006 Jul;29(7):1585-90.
26. International Diabetes Federation. Morbidity and mortality. IDF Diabetes Atlas, 4th edn. Brussels, Belgium: International Diabetes Federation, 2009
27. International Diabetes Federation. Diabetes in low-, middle-, and high-income countries. IDF Diabetes Atlas, 5th edn. Brussels, Belgium: International Diabetes Federation, 2011.
28. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002 Oct;25(10):1862-8. Review.
29. International Diabetes Federation. Global guideline on pregnancy and diabetes. IDF Diabetes Atlas, 4th edn. Brussels, Belgium: International Diabetes Federation, 2009
30. Dornhorst A, Rossi M. Risk and prevention of type 2 diabetes with women with gestational diabetes [abstract]. Diabetes Care 1998;21(Suppl 2):B43-9.
31. International Association of Diabetes and Pregnancy Study Groups Consensus Panel. Internation Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33(3): 676-682.
32. Fajans S, Bell GI, Polonsky K. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. NEJM. 2001;345(13):971-980.
33. Winter WE and Silverstein JH. Molecular and genetic basis for maturity onset diabetes of youth. Curr Opin Pediatr 2000; 12(4): 388-393.
34. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2003; 26(Suppl 1): s5-s20.
35. Tuomi, T., L. C. Groop, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes 1993; 42(2): 359-362.
36. Appel, S. J., T. M. Wadas, et al. Latent autoimmune diabetes of adulthood (LADA): an often misdiagnosed type of diabetes mellitus. J Am Acad Nurse Pract. 2009; 21(3): 156-159.
37. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes? J Alzheimers Dis. 2005 Feb;7(1):63-80.
38. Kroner, Z. The relationship between Alzheimer's disease and diabetes: Type 3 diabetes? Altern Med Rev. 2009; 14(4): 373-379.
39. Balasubramanyam A, Nalini R, et al. Syndromes of ketosis-prone diabetes mellitus. Endocr Rev. 2008;29(3): 292-302.
40. Samarasinghe S, Vokes T. Diabetes insipidus. Expert Rev Anticancer Ther. 2006;6( Suppl 9): S63-74.

Return To Top